Department of Pediatrics, University of California, San Francisco, Calif; Cardiovascular Research Institute, University of California, San Francisco, Calif.
Department of Pediatrics, University of California, San Francisco, Calif.
J Thorac Cardiovasc Surg. 2014 Jul;148(1):212-9. doi: 10.1016/j.jtcvs.2013.08.009. Epub 2013 Sep 27.
The study objective was to determine the association between preoperative B-type natriuretic peptide levels and outcome after total cavopulmonary connection. Surgical palliation of univentricular cardiac defects requires a series of staged operations, ending in a total cavopulmonary connection. Although outcomes have improved, there remains an unpredictable risk of early total cavopulmonary connection takedown. The prediction of adverse postoperative outcomes is imprecise, despite an extensive preoperative evaluation.
We prospectively enrolled 50 patients undergoing total cavopulmonary connection. We collected preoperative clinical data, preoperative plasma B-type natriuretic peptide levels, and postoperative outcomes, including the incidence of an adverse outcome within 1 year of surgery (defined as death, total cavopulmonary connection takedown, or the need for cardiac transplantation).
The mean age of patients was 4.7 years (standard deviation, 2.1 years). The median (interquartile range) preoperative B-type natriuretic peptide levels were higher in patients who required total cavopulmonary connection takedown and early postoperative mechanical cardiac support (n = 3; median, 55; interquartile range, 42-121) compared with those with a good outcome (n = 47; median, 11; interquartile range, 5-17) (P < .05). A preoperative B-type natriuretic peptide level of 40 pg/mL or greater was highly associated with the need for total cavopulmonary connection takedown (sensitivity, 100%; specificity, 93%; P < .05), yielding a positive predictive value of 50% and a negative predictive value of 100%. Higher preoperative B-type natriuretic peptide levels also were associated with longer intensive care unit length of stay, longer hospital length of stay, and increased incidence of low cardiac output syndrome (P < .05).
Preoperative B-type natriuretic peptide blood levels are uniquely associated with the need for mechanical support early after total cavopulmonary connection and total cavopulmonary connection takedown, and thus may provide important information in addition to the standard preoperative assessment.
本研究旨在探讨术前 B 型利钠肽(B-type natriuretic peptide,BNP)水平与全腔静脉肺动脉连接(total cavopulmonary connection,TCPC)术后结局之间的关系。单心室心脏缺陷的手术姑息治疗需要一系列分期手术,最终进行 TCPC。尽管治疗效果已有改善,但 TCPC 重建术后仍存在早期重建失败的不可预测风险。尽管进行了广泛的术前评估,但术后不良结局的预测仍不够精确。
前瞻性纳入 50 例行 TCPC 患者。收集患者术前临床资料、术前血浆 BNP 水平及术后结局,包括术后 1 年内发生不良事件(定义为死亡、TCPC 重建失败或需要心脏移植)的发生率。
患者平均年龄为 4.7 岁(标准差为 2.1 岁)。需要 TCPC 重建失败和早期术后机械性心脏支持的患者术前 BNP 中位数(四分位距)较高[3 例患者,55(42121)pg/ml],而结局良好的患者[47 例患者,11(517)pg/ml]则较低(P <.05)。术前 BNP 水平≥40 pg/ml 与 TCPC 重建失败高度相关(敏感性为 100%,特异性为 93%,P <.05),阳性预测值为 50%,阴性预测值为 100%。术前较高的 BNP 水平还与 ICU 住院时间延长、住院时间延长和低心排血量综合征发生率增加相关(P <.05)。
术前 BNP 血水平与 TCPC 术后早期需要机械支持和 TCPC 重建失败独立相关,因此除了标准的术前评估外,可能还提供了重要信息。